8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-23-034510
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading avtx-20231016.htm…